- Home
- TWFG vs TLRY Comparison
TWFG vs TLRY Comparison
Compare TWFG & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWFG
- TLRY
- Stock Information
- Founded
- TWFG 2001
- TLRY N/A
- Country
- TWFG United States
- TLRY Canada
- Employees
- TWFG N/A
- TLRY N/A
- Industry
- TWFG
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- TWFG
- TLRY Health Care
- Exchange
- TWFG NYSE
- TLRY Nasdaq
- Market Cap
- TWFG 530.3M
- TLRY 502.9M
- IPO Year
- TWFG 2024
- TLRY 2018
- Fundamental
- Price
- TWFG $35.25
- TLRY $0.37
- Analyst Decision
- TWFG Buy
- TLRY Hold
- Analyst Count
- TWFG 8
- TLRY 3
- Target Price
- TWFG $33.71
- TLRY $1.38
- AVG Volume (30 Days)
- TWFG 70.3K
- TLRY 28.7M
- Earning Date
- TWFG 05-13-2025
- TLRY 07-28-2025
- Dividend Yield
- TWFG N/A
- TLRY N/A
- EPS Growth
- TWFG N/A
- TLRY N/A
- EPS
- TWFG N/A
- TLRY N/A
- Revenue
- TWFG $211,440,000.00
- TLRY $826,656,000.00
- Revenue This Year
- TWFG $23.90
- TLRY $9.91
- Revenue Next Year
- TWFG $22.60
- TLRY $5.94
- P/E Ratio
- TWFG N/A
- TLRY N/A
- Revenue Growth
- TWFG 18.57
- TLRY 11.22
- 52 Week Low
- TWFG $21.31
- TLRY $0.36
- 52 Week High
- TWFG $36.85
- TLRY $2.15
- Technical
- Relative Strength Index (RSI)
- TWFG N/A
- TLRY 37.37
- Support Level
- TWFG N/A
- TLRY $0.37
- Resistance Level
- TWFG N/A
- TLRY $0.43
- Average True Range (ATR)
- TWFG 0.00
- TLRY 0.03
- MACD
- TWFG 0.00
- TLRY -0.00
- Stochastic Oscillator
- TWFG 0.00
- TLRY 4.78
About TWFG TWFG INC
TWFG Inc is a independent distribution platform for personal and commercial insurance in the United States. It offers all lines of insurance, multiple distribution contract options, M&A services, proprietary virtual assistants, proprietary technology, proprietary premium financing, unlimited continuing education, recognition programs, co-op funding, marketing support and overall lower costs to operate.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.